Details of the Active Pharmaceutical Ingredient (API)
General Information of API (ID: D00111) | |||||
---|---|---|---|---|---|
Name |
Ceftibuten
|
||||
Synonyms |
Click to Show/Hide the Synonyms of This API
ceftibuten; 97519-39-6; Ceftibuteno; Ceftibutenum; Ceftibutene; Sch 39720; cis-ceftibuten; UNII-IW71N46B4Y; Sch-39720; Ceftibuten hydrate; 7432-S; Antibiotic 7432S; CHEBI:3510; IW71N46B4Y; CEFTIBUTEN DIHYDRATE; 97519-39-6 (free); Isocef; MFCD00864918; (+)-(6R,7R)-7-((Z)-2-(2-Amino-4-thiazolyl)-4-carboxycrotonamido)-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid; cis-Ceftibutin; 5-Thia-1-azabicyclo(4.2.0)oct-2-ene-2-carboxylic acid, 7-((2-(2-amino-4-thiazolyl)-4-carboxy-1-oxo-2-butenyl)amino)-8-oxo-, (6R-(6alpha,7beta(Z)))-; Cephalosporin 7432-S; (6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-4-carboxybut-2-enamido)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; Ceftibutene [INN-French]; Ceftibutenum [INN-Latin]; Ceftibuteno [INN-Spanish]; Ceprifran; Ceftem; Keimax; Ceftibuten [USAN:INN:BAN]; S 7432; NCGC00095137-01; Ceftibuten, 95%; Ceftibuten (USAN/INN); Spectrum5_001558; CHEMBL1605; DSSTox_CID_25925; DSSTox_RID_81227; DSSTox_GSID_45925; SCHEMBL37054; ACHN383; BSPBio_002733; SPECTRUM1505207; ACHN-383; DTXSID4045925; HMS1922L17; HMS2093K18; HMS3715P10; Pharmakon1600-01505207; HY-B0698; ZINC3871967; Tox21_111446; BDBM50370586; CC0255; CCG-39440; NSC758925; AKOS005146205; AKOS015854930; DB01415; NSC-758925; NCGC00178501-01; NCGC00178501-04; SBI-0206740.P001; CAS-97519-39-6; C08117; D00922; AB01563048_01; 519C396; Ceftibuten, Antibiotic for Culture Media Use Only; Q419521; SR-05000001989; SR-05000001989-1; 7-[2-(2-Amino-1,3-thiazol-4-yl)-4-carboxyisocrotonamide]-3-cephem-4-carboxylicacid; (6R,7R)-7-[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enamido]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-4-carboxy-1-oxo-2-buten-1-yl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid; (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-4-carboxy-1-oxo-2-buten-1-yl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid hydrate; (6R,7R)-7-[[(Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; (6R,7R)-7-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino}-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; 7beta-{[(2Z)-2-(2-amino-1,3-thiazol-4-yl)-4-carboxybut-2-enoyl]amino}-3,4-didehydrocepham-4-carboxylic acid
|
||||
Clinical Status |
Approved
|
||||
Disease Indication | Bronchitis | ICD-11: CA20 | [1] | ||
PubChem CID | |||||
Formula |
C15H14N4O6S2
|
||||
Canonical SMILES |
C1C=C(N2[C@H](S1)[C@@H](C2=O)NC(=O)/C(=C\\CC(=O)O)/C3=CSC(=N3)N)C(=O)O
|
||||
InChI |
1S/C15H14N4O6S2/c16-15-17-7(5-27-15)6(1-2-9(20)21)11(22)18-10-12(23)19-8(14(24)25)3-4-26-13(10)19/h1,3,5,10,13H,2,4H2,(H2,16,17)(H,18,22)(H,20,21)(H,24,25)/b6-1-/t10-,13-/m1/s1
|
||||
InChIKey |
UNJFKXSSGBWRBZ-BJCIPQKHSA-N
|
||||
Click to Show/Hide the Molecular Data (Structure/Property) of This API | |||||
Structure |
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=5282242"></iframe>
|
||||
3D MOL | 2D MOL | ||||
Physicochemical Properties | Molecular Weight | 410.4 | Topological Polar Surface Area | 217 | |
XlogP | -0.3 | Complexity | 755 | ||
Heavy Atom Count | 27 | Rotatable Bond Count | 6 | ||
Hydrogen Bond Donor Count | 4 | Hydrogen Bond Acceptor Count | 10 | ||
Full List of Drug Formulations (DFMs) Containing This API | ||||||
---|---|---|---|---|---|---|
Ceftibuten 400 mg capsule | Click to Show/Hide the Full List of Formulation(s): 2 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Sodium lauryl sulfate; Butylparaben; Benzyl alcohol; Magnesium stearate; Propylparaben; Sodium propionate; Edetate calcium disodium; Titanium dioxide; Polysorbate 80; Cellulose, microcrystalline; Gelatin; Sodium starch glycolate type a potato
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Macoven Pharmaceuticals; Pernix Therapeutics | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Benzyl alcohol | DIG Info | Indoleamine 2,3-dioxygenase 1 (IC50 = 1400 nM) | [3] | |||
Butylparaben | DIG Info | Estrogen receptor alpha (IC50 = 1420 nM) | [4] | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [6] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [6] | |||
Magnesium stearate | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
Drug Formulation 2 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Methylparaben; Sodium lauryl sulfate; Butylparaben; Benzyl alcohol; Propylparaben; Sodium propionate; Edetate calcium disodium; Titanium dioxide; Polysorbate 80; Gelatin
|
|||||
Dosage Form | Oral Capsule | |||||
Company | Sciele Pharma, Inc. | |||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
methylparaben | DIG Info | Carbonic anhydrase VII (Ki = 780 nM) | [2] | |||
Benzyl alcohol | DIG Info | Indoleamine 2,3-dioxygenase 1 (IC50 = 1400 nM) | [3] | |||
Butylparaben | DIG Info | Estrogen receptor alpha (IC50 = 1420 nM) | [4] | |||
Sodium lauryl sulfate | DIG Info | Solute carrier SLCO2B1 (Ki = 1.98 uM) | [5] | |||
Propyl 4-hydroxybenzoate | DIG Info | Estrogen receptor alpha (IC50 = 11 uM) | [6] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [6] | |||
Ceftibuten Dihydrate eq 400mg base capsule | Click to Show/Hide the Full List of Formulation(s): 1 Formulation(s) | |||||
Drug Formulation 1 | DFM Info click to show the detail info of this DFM | |||||
All DIGs | Click to Show/Hide the Full List of DIGs in This DFM
Cherry Flavoring; Polysorbate 80; Silicon Dioxide; Simethicone; Sodium Benzoate; Sucrose; Titanium Dioxide; Xanthan Gum
|
|||||
Dosage Form | Capsule | |||||
Company | ||||||
DIG(s) with Biological Activity | ||||||
DIG Name | DIG Info | Representative Biological Activity of This DIG | REF | |||
Simethicone | DIG Info | Opioid receptor mu (IC50 = 1.5 nM) | [8] | |||
Sodium benzoate | DIG Info | Carbonic anhydrase II (Ki = 30000 nM) | [9] | |||
Polysorbate 80 | DIG Info | Prostaglandin G/H synthase 1 (IC50 = 1 uM) | [6] | |||
Silicon dioxide | DIG Info | Albendazole monooxygenase (Protein expression downregulation) | [7] | |||
If you find any error in data or bug in web service, please kindly report it to Dr. Zhang and Dr. Mou.